Gene Expression Patient Stratification Tool for Immuno-Oncology Biomarker Signature Scoring for Risk Mitigation CAPA Planning for Policy Update Readiness Checkpoint
Score tumor RNA-seq samples from 150 NSCLC patients using published immune gene expression signatures (TIS, IFN-γ, T cell-inflamed GEP) and stratify patients into immune phenotypes for IO therapy response prediction.